Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Peretz

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Harefuah|September 12, 2002
[Tamoxifen and breast cancer]Hovav Nechushtan, Tamar Peretz
Pediatric Dentistry|January 22, 2004
The effect of chemotherapy in pregnant women on the teeth of offspringBenjamin Peretz, Tamar Peretz
The Israel Medical Association Journal : IMAJ|May 13, 2009
Extreme high levels of CA19-9 associated with adenocarcinoma of the lungYakir Rottenberg, Benjamin Nisman, Tamar Peretz
Onkologie|March 31, 2011
Liver failure on the background of pseudocirrhosis in patients with liver metastasis from breast cancer, who responded to treatmentAmir Sonnenblick, Liat Appelbaum, Tamar Peretz
Fertility and Sterility|January 9, 2018
BRCA mutations and reproductionHagit Daum, Tamar Peretz, Neri Laufer
Familial Cancer|May 26, 2006
Acceptance of preventive surgeries by Israeli women who had undergone BRCA testingVardit Kram, Tamar Peretz, Michal Sagi
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 23, 2005
Sporadic breast cancer among relatives of BRCA mutation carriersTanir M Allweis, Michal Sagi, Tamar Peretz
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 16, 2014
Silent Partners to Cancer Patients: Formal Caregivers and OncologistsG Goldzweig, Yakir Rottenberg, Tamar Peretz, et al.
Breast (Edinburgh, Scotland)|August 9, 2005
BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to useTal Grenader, Tamar Peretz, Meyer Lifchitz, et al.
Journal of the National Cancer Institute|February 3, 2005
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancerTal Grenader, Linda Shavit, Beatrice Uziely, et al.
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Harefuah|September 12, 2002
[Tamoxifen and breast cancer]Hovav Nechushtan, Tamar Peretz
Pediatric Dentistry|January 22, 2004
The effect of chemotherapy in pregnant women on the teeth of offspringBenjamin Peretz, Tamar Peretz
The Israel Medical Association Journal : IMAJ|May 13, 2009
Extreme high levels of CA19-9 associated with adenocarcinoma of the lungYakir Rottenberg, Benjamin Nisman, Tamar Peretz
Onkologie|March 31, 2011
Liver failure on the background of pseudocirrhosis in patients with liver metastasis from breast cancer, who responded to treatmentAmir Sonnenblick, Liat Appelbaum, Tamar Peretz
Fertility and Sterility|January 9, 2018
BRCA mutations and reproductionHagit Daum, Tamar Peretz, Neri Laufer
Familial Cancer|May 26, 2006
Acceptance of preventive surgeries by Israeli women who had undergone BRCA testingVardit Kram, Tamar Peretz, Michal Sagi
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 23, 2005
Sporadic breast cancer among relatives of BRCA mutation carriersTanir M Allweis, Michal Sagi, Tamar Peretz
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|October 16, 2014
Silent Partners to Cancer Patients: Formal Caregivers and OncologistsG Goldzweig, Yakir Rottenberg, Tamar Peretz, et al.
Breast (Edinburgh, Scotland)|August 9, 2005
BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to useTal Grenader, Tamar Peretz, Meyer Lifchitz, et al.
Journal of the National Cancer Institute|February 3, 2005
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancerTal Grenader, Linda Shavit, Beatrice Uziely, et al.
Pageof 22